Literature DB >> 11718071

[Clinic intervention study on urogenital mycoplasma infection of pregnant women].

Y Ye1, S Tu, H Li.   

Abstract

OBJECTIVE: To explore the hypothesis of pathogenic relationship between urogenital mycoplasma infection and adverse perinatal outcomes.
METHODS: Four hundred and eighty-eight mycoplasma-positive pregnant women detected by culture method were randomly divided into erythromycine-intervention group and non-intervention group. Comparison was made on rate of reverse sero-conversion, of vertical transmission to mycoplasma and adverse perinatal outcomes incidence between groups.
RESULTS: Ureaplasma urealyticum sero-conversion rate and rate of vertical-transmission in intervention group were significantly lower than in non-intervention group (P < 0.05). The incidences rates of preturm labor, post partum fever, puerperal infection and neonate pneumonia in intervention group were significantly lower than in non-intervention group (P < 0.05).
CONCLUSION: Erythromycin is effective in control of ureaplasma urealyticum infection among pregnant women through cutting off vertical transmission passway and lowering adverse perinatal outcomes against ureaplasma urealyticum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11718071

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

Review 1.  Antibiotics for ureaplasma in the vagina in pregnancy.

Authors:  Camille H Raynes Greenow; Christine L Roberts; Jane C Bell; Brian Peat; Gwendolyn L Gilbert; Sharon Parker
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

2.  Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: A systematic review and meta-analysis.

Authors:  Heng Fan; Leah Li; Linda Wijlaars; Ruth E Gilbert
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

3.  Positive culture rate and antimicrobial susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum.

Authors:  Young-Soo Jang; Ji-Won Min; Yun-Sook Kim
Journal:  Obstet Gynecol Sci       Date:  2019-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.